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ABSTRACT  
Patients after vestibular neuritis (VN) often report persistent dizziness and 
disequilibrium. We correlated persistent symptoms with sustained impairment of the 
high-acceleration horizontal vestibulo-ocular reflex as determined by quantitative 
search-coil head-impulse testing (qHIT). In 47 patients, qHIT was recorded 0-60 
months and symptoms assessed with the Yardley Vertigo Symptom Scale short form 
≥18 months after VN onset. No correlation between the magnitude of high-
acceleration vestibular impairment and the severity of vertigo symptoms was 
observed. The lack of symptom-qHIT correlation suggests that defective 
compensation at more rostral level in the central nervous system may be responsible 
for protracted symptoms in VN patients.  
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INTRODUCTION 
Vestibular neuritis (VN) is defined as a sudden unilateral deficit of the peripheral 
vestibular organ (labyrinth or nerve) without auditory symptoms in otherwise healthy 
subjects. Signs and symptoms result from an imbalance of the tonic discharge 
between the impaired and intact vestibular afferent. Recovery is due to a combination 
of peripheral vestibular restoration and central compensation [4]. The time course of 
recovery varies between individuals and, contrary to conventional clinical knowledge 
[3], almost 50 % of patients with VN report sustained dizziness and disequilibrium [2, 
5, 6, 9, 11, 12]. Vestibular function when assessed by caloric irrigation, rotatory chair 
testing, posturography, or clinical balance testing does not seem to differ between 
patients with sustained symptoms and symptom-free patients [2, 6, 10-12]. However, 
a limitation of the latter studies is that they all rely on measurements of low-frequency 
components of vestibular function. This is important because Schmid-Priscoveanu et 
al. showed that the low-frequency vestibular function, as determined by caloric 
irrigation, becomes symmetrical whereas the high-frequency function, assessed by 
quantitative search-coil head-impulse testing (qHIT), remains impaired [14]. Since the 
vestibular apparatus is most efficient when transducing high-frequency components of 
head motion, such as occur during locomotion, it would be reasonable to expect 
symptoms to correlate with the qHIT. We therefore set out to compare sustained 
residual vestibular symptoms, as assessed by the shortened version of the Yardley 
Vertigo Symptom Scale (sVSS), with qHIT in VN patients. 
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METHODS 
Subjects: Forty-seven patients (27 male, 33 – 87 y [49 ± 15]) diagnosed with 
unilateral peripheral vestibular hypofunction due to VN participated in the study. All 
patients had developed acute vertigo without additional auditory or neurological 
symptoms and displayed spontaneous horizontal-torsional nystagmus and a 
pathological unilateral bedside head-impulse test during clinical examination. Patients 
were divided into two groups depending on the time interval between VN onset and 
the date of qHIT (acute: 1 day – 4 weeks, N = 14; chronic: > 4 weeks – 60 months, N 
= 33). The acute/chronic cutoff point was based on a previous study showing that the 
vast majority of improvement in qHIT takes place within 4 weeks after VN onset 
[13]. Twelve acute patients were tested twice at different time after VN onset; the first 
qHIT measurement was within the first 4 weeks after VN onset in all 12 patients and 
the subsequent measurement was over 4 weeks (first qHIT: 1.3 SD 1.5 weeks; 
subsequent: 13 SD 19 months). The comparison group for qHIT data comprised 28 
healthy subjects (13 male, 18-75 y). Informed consent was obtained from all 
participants and the protocol was approved by the local ethics committee, in 
accordance with the 1964 Declaration of Helsinki.  
qHIT: Three-dimensional eye and head movements were recorded in a magnetic 
frame (Remmel type system, modified by A. Lasker, Baltimore, MA, USA) using 
dual search-coils. Search-coils were calibrated before each session (see Straumann et 
al.[15] for details). Horizontal head impulses (amplitude: 20-40°; duration: 150-200 
ms; peak velocity: ∼ 300 °/s; peak acceleration: ∼ 10000 °/s2) were applied by an 
investigator standing behind the subject who was visually fixing upon a target light 
1.24m straight ahead. The direction of the head impulses was pseudorandomized and 
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four to six impulses were performed in each direction. The gain of the horizontal 
vestibulo-ocular reflex (VOR) was determined by computing the coefficient ‘eye-in-
space displacement divided by head-in-space displacement’ as head-in-space moved 
from 3° to 7° eccentricity from straight-ahead. We used this analysis to rule out any 
possible effect of latency on gain, since it is not known whether VN affects only the 
gain or, in addition, also the latency of the VOR. An increased latency, however, 
would lead to a false reduction of gain if determined at peak head velocity [13].  
Gain asymmetry (gVORasym) in percent was computed by: 
ipsigVORgVORcontra
gVORipsigVORcontraasymgVOR +
−=  
whereby gVORipsi denotes the VOR gain during head impulses to the ipsilesional 
side and gVORcontra the VOR gain during head impulses to the other side. 
Vertigo symptom scale: 2 - 98 months (46 SD 27) after vestibular examination, 
patients were asked to complete the shortened version of the Yardley Vertigo 
Symptom Scale (sVSS), measuring the frequency of dizziness, vertigo, imbalance, 
and related autonomic symptoms during the past 12 months [19-21]. 
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RESULTS 
Figure 1 plots gains of the horizontal VOR for qHIT towards the ipsilesional side 
(Fig. 1 left diagrams) and gain asymmetry between the contra- and ipsilesional side 
(Fig. 1 right diagrams) as a function of sVSS in all patients (Fig. 1AB) as well as in 
the chronic (Fig. 1CD) and acute (Fig. 1EF) groups. Age was not significantly 
different between symptom-free and symptomatic patients (unpaired t-test: p = 0.6). 
Neither in all patients (Fig. 1AB) nor in the chronic patient group (Fig. 1 CD) did 
ipsilesional qHIT gains or gain asymmetries correlate with sVSS scores (Spearman 
rank correlation coefficients ranging between -0.07 to 0.15, p-values > 0.1). In acute 
patients, contrary to what may be expected, low ipsilesional qHIT gains (Fig. 1E) and 
large gain asymmetries (Fig. 1F) tended to relate to low sVSS scores (i.e. less 
vertigo), but the correlation was not significant (gVORipsi: Spearman rank correlation 
= 0.51, p = 0.06;  gVORasym: Spearman rank correlation = -0.51, p = 0.06).  
/* FIGURE 1 ABOUT HERE */ 
Figure 2 shows ipsilesional qHIT gains (A) and corresponding gain differences 
between the two assessments (B) plotted as a function of sVSS scores in the 12 
patients who were tested twice after VN onset. The interval between the first (Fig. 2A, 
circle) and the subsequent (Fig. 2A, cross) measurement ranged within 1 – 60 months 
(13 SD 19 months). Low sVSS scores appeared to correlate with large ipsilesional 
gain improvement (Fig. 2B), although this correlation was not significant (Spearman 
rank correlation = -0.3, p = 0.3).  
/* FIGURE 2 ABOUT HERE */ 
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DISCUSSION 
Our study demonstrates that persistent dizziness after VN is not significantly 
associated to sustained vestibular impairment as assessed by the quantitative search-
coil head impulse testing (qHIT). More specifically, severe vestibular deficit in the 
chronic patient group did not imply a high score on the shortened version of the 
Vertigo Symptom Scale (sVSS), assessing dizziness, vertigo and imbalance during 
the past 12 months. Although a lack of congruency between persistent symptoms and 
vestibular function tests has been described previously in patients with VN [2, 5, 10-
12], this is the first study showing that this conclusion also holds for the high-
frequency components of vestibular function.  
The fact that sVSS assessment in our study was conducted on average about 4 years 
after vestibular examination could be viewed as a limitation of this study. However, 
our explicit aim was to ascertain the presence of protracted symptoms in VN patients. 
We do not expect that this time interval had a major impact on the correlation of 
vestibular function in chronic VN patients, since qHIT measurements were also 
obtained when peripheral recovery and/or central compensation were stabilized [13]. 
Further, the lack of correlation between persistent symptoms and high-frequency 
VOR function is unlikely to depend on sample size, as revealed by post-hoc statistical 
power analysis (see Legend Figure 1).  
A potentially interesting observation was that the two patients with very high sVSS-
scores showed a combination of only mild to moderate ipsilesional gain impairment 
and scarce gain improvement over time (Figure 2). This finding, which might suggest 
a greater risk to develop chronic vertigo if gain impairment or improvement are less 
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pronounced, needs to be verified in more patients. Such an analysis is particularly 
important in the light of recent suggestions that steroid treatment for acute VN 
improves peripheral-vestibular recovery (albeit measured with the caloric test and 
without symptom assessment) [1, 16].  
What could be the main determinants of the long term clinical recovery after acute 
VN given that residual symptoms are not correlated to conventional vestibular 
function tests (ie caloric or qHIT)? First, persistent otolith imbalance could account 
for sustained vestibular symptoms. To our knowledge, the only study assessing otolith 
function and vestibular symptoms did not find differences in vestibular evoked 
myogenic potential responses between symptom-free and symptomatic VN patients 
[11]. Vestibular evoked myogenic potentials, however, appraise saccular but not 
utricular function, which typically is affected in VN. Second, enhancement of the 
deficient VOR by early catch-up saccades, a strategy which assists gaze stabilization 
[18], but is not routinely assessed, may be insufficient in some patients. Therefore, 
one could speculate that residual symptoms in VN patients are correlated with poor 
saccadic VOR enhancement. Finally, deficient cortical adaptation, including 
psychophysical and psychological processes, could be responsible for protracted 
symptoms in VN patients [6-8, 17]. Longitudinal assessments of such central 
processes in VN patients, however, remain the purpose of further investigations. 
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FIGURE LEGENDS 
Figure 1. Horizontal VOR gains during qHIT towards the ipsilesional side (left 
diagrams) and gain asymmetry (right diagrams) plotted as a function of sVSS scores. 
Triangles (A, B): all patients (N = 47); squares (C, D): chronic patients (N = 33); 
crosses (E, F): acute patients (N = 14). gVORipsi: VOR gains for ipsilesional qHIT; 
gVORasym: percentage of gain asymmetry between contra- and ipsilesional VOR gains 
(see Methods for definition). Horizontal dashed lines: lower limit of average VOR 
gains for healthy subjects - 2SD; vertical dashed lines: zero sVSS score corresponding 
to complete symptom absence. Diagonal solid lines: linear regression slopes 
optimized by linear squares estimation; the corresponding statistics (rho and p) 
indicate the strength of the relationship between the two variables obtained with 
nonparametric Spearman statistics. Post-hoc statistical power analyses for linear 
regressions with one predictor revealed adequate samples sizes for acute and chronic 
patient groups (power > 0.80).  
Figure 2. Horizontal VOR gains for the first and subsequent ipsilesional qHIT 
measurement (A) and corresponding gain differences (B) plotted as a function of 
sVSS scores in acute patients (N = 14). Circles: ipsilesional VOR gains (gVORipsi) 
resulting from first qHIT measurement (i.e. within 4 weeks after VN onset); crosses: 
ipsilesional VOR gains (gVORipsi) resulting from subsequent qHIT measurement (i.e. 
> 4 weeks from VN onset). Δ gVORipsi: gVORipsi first measurement - gVORipsi 
subsequent measurement. Solid and dashed lines as in Figure 1. 
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